New developments in hepatitis A control.

Preventing hepatitis A infections. National Advisory Committee on Immunization statement. Laboratory Centre for Disease Control. Can Fam Physician (1995) 0.75

Double dose of protection. Can Fam Physician (1995) 0.75

Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science (1973) 5.82

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med (1992) 4.05

Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med (1979) 3.89

Type A viral hepatitis. New developments in an old disease. N Engl J Med (1985) 2.86

Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578). Proc Soc Exp Biol Med (1975) 2.59

Hepatitis in day care centers: epidemiology and prevention. Rev Infect Dis (1986) 1.78

Stability of hepatitis A virus. Intervirology (1984) 1.70

Epidemiological patterns of hepatitis A in different parts of the world. Vaccine (1992) 1.53

Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine (1992) 1.34

Multistate outbreak of hepatitis A associated with frozen strawberries. J Infect Dis (1992) 1.19

Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations. Vaccine (1993) 1.19

A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol (1990) 1.18

Secular trends in hepatitis A virus infection among Alaska Natives. J Infect Dis (1993) 1.15

Prevalence and incidence of hepatitis A among male homosexuals. Br Med J (Clin Res Ed) (1983) 1.14

Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A. Am J Public Health (1990) 1.03

Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis (1993) 1.02

Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine (1992) 1.01

Posttransfusion hepatitis type A. JAMA (1983) 0.97

An outbreak of hepatitis A among health care workers: risk factors for transmission. Am J Public Health (1993) 0.96

Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Vaccine (1993) 0.94

Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine (1992) 0.93

Intravenous drug use and hepatitis A: an investigation of an outbreak. Can J Public Health (1990) 0.92

Ecology and prevention of a shellfish-associated hepatitis A epidemic in Shanghai, China. Vaccine (1992) 0.91

Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection. JAMA (1976) 0.90

Hepatitis A in young Norwegian drug addicts and prison inmates. Infection (1988) 0.89

Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. CMAJ (1993) 0.85

An epidemic of hepatitis A in an institution for young children. Am J Epidemiol (1987) 0.84

Hepatitis A--investigation and control of outbreaks in two primary schools. Public Health (1986) 0.83

Hepatitis A and hepatitis B virus infections in day-care settings. Pediatr Ann (1991) 0.79

Vaccine storage and handling. Knowledge and practice in primary care physicians' offices. Can Fam Physician (1995) 2.34

Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ (1997) 1.14